Cannabidiol (CBD) is unquestionably one of the most significant substances in the Hemp plant (Cannabis Sativa), with its healing and anti-inflammatory properties. In fact, it also works against convulsions, anxiety, insomnia, neuropathic pain, ulcers, and other conditions. Authorities target THC, but not CBD because THC has psychoactive characteristics and is the main “drug” found in cannabis.
Naturally, both THC and CBD are prime cannabinoids, but CBD has far more beneficial properties without the psychoactive properties. As we are figuring this out, we are refining our legal and scientific premises regarding this special plant. For example, it used to be the case that the whole plant was illegal, but now we are seeing changes that allow for the emergence of CBD as an important therapeutic substance.
Cannabidiol has distinctive healing effects, contingent upon whether it is plant-determined CBD Hemp Oil with a characteristic proportion of alternate cannabinoids, or supposed cleansed or manufactured Cannabidiol with slight or zero concentrations of THC. Cannabidiol is most regularly gotten by means of extraction from Hemp, which for the most part contains a CBD substance of around 4% and a THC level of generally under 0.6%.
In the big picture, we know the goal is to end up with a high concentration of CBD and low concentration of THC. We want to isolate the anti-inflammatory and healing properties, and leave out the psychoactive ones. The process of generating CBD hemp oil has progressed along those lines with that in mind.
The Research Front
Czech scientist Lumír Ondřej Hanuš from the Hebrew University in Jerusalem has been one of the most notable researchers in this field.
His work compared the effects of natural and purified Cannabidiol on inflammation and pain. Findings from this work included data supporting the idea that these two substances are in fact very different in their effects, despite seeming identicality from a superficial aspect. The data actually concentrated on mice with inflammation, but we have already observed similar results in human studies.
The key is this: Pure CBD showed material results on administration after being given over intervals with scaling dosage increases. Reaction to these further measurements specifically related to the expanding dose, yet when a specific level of quality of the dose was achieved, expanding the dose demonstrated no change and had in truth debilitated contrasted with the lower doses.
This impact has been seen previously and has demonstrated that Cannabidiol isn’t suggested for the treatment of inflammation – the tests were finished with isolated or synthetic CBD. In this experiment, a Glock curve was generated, after which the entire study was named ‘Overcoming the Bell-Shaped Dose Response of Cannabidiol by Using Cannabis Extract Enriched in Cannabidiol’.
But here’s the interesting part: they got a completely different result when they used a plant extract Cbd Hemp Oil from the Israeli cultivar Avidekel containing CBD 18% and THC <1% for the treatment of inflammation.
In that case, the extract brought about an escalating response in proportion to the dosage scale. In other words, the extract containing the whole spectrum of cannabinoids works for inflammation as a treatment.
CBD Oil and Medical Orthodoxy
At the point when contrasted with headache medicine and tramadol, which are normally utilized medications for inflammation and pain, Cannabidiol had a substantially more profound impact on the inflammation, while the impact on pain was less significant. But analysts accordingly demonstrated that the concentrate of the Hemp plant (Cannabis Sativa) contains substances which have an impact on the conduct of the Cannabidiol and enhance its effects.
The substances contained in Hemp shape a cooperative energy and commonly fortify and tweak the impact of the plant on the body.
This synergistic impact is lost when CBD Hemp Oil is isolated. Pediatric epilepsy offers an interesting case for analysis.
If commercial CBD Hemp Oil is exchanged for an extract containing a mixture of 1/20 CBD and 1/200 THC, a key difference can be revealed.
Albeit the two arrangements had an indistinguishable CBD (5%) content, the commercial CBD oil with no THC content lacked that element of a little THC. The key here is that the small amount of THC in the variation is neutralized by the CBD, making it safe for even young children. But the small amount of THC might actually help in the process.
Safe Extraction of CBD Oil
It is certainly possible to safely extract CBD Oil. But all methods are the same, and it is important to understand the differences.
For instance: when you utilize solvents, for example, butane and hexane, which are neuro-dangerous substances. Conceivable buildups of these neuro-poisons that may stay in the oil could contrarily influence ones odds of recuperating, and when all is said in done neuro-poisons are not attractive in whichever ever little sums on account of conceivable organ harm that may occur regardless of the way that the CBD Oil itself is intended to mend.
To extricate the oil by means of CO2 extraction includes using profoundly compacted carbon dioxide and to a great degree low temperatures.
This technique segregates and holds the immaculateness of the CBD therapeutic oil, however involves having exorbitant mechanical assembly and a steep course to possible achievement.
Be that as it may, when done accurately the final result is sheltered, powerful chlorophyll free. Utilizing Ethanol brings about top notch Cannabis oil that can be utilized for vape pens. Take mind with this strategy, however. Natural waxes, which may have medical advantages, are eradicated simultaneously.
Olive oil, regardless of whether additional virgin or not, can likewise be used for the extraction of Cannabis Oil.
In any case, note, since it is an Oil Maceration it is additionally by a wide margin not as powerful to discharge the Cannabinoids from the Plant material.
Being both safe a reasonable, utilizing this technique is prescribed by Dr. Arno Hazekamp, Director of Phytochemical Research at Bedrocan BV.
Finally, olive oil is perishable so you will want to store it in conditions that prevent deterioration, avoiding light and heat.
BevCanna A Leader In The North American Infused Beverage Sector
Why BevCanna May Already Have Pole Position for the Coming Cannabis Beverage Craze
New Opportunity: BevCanna Enterprises Inc. (CSE:BEV) (OTC:BVNNF)
- Leader/Innovator in Emerging multi-billion-dollar Cannabis-Infused Beverage space
- Recently announced coming transition to full commercial-stage operations in coming months
- Set to become Canada’s largest organic outdoor cannabis cultivator
- World-class bottling facility about to receive full cannabis-infused bev production license
- Launching in California and Canada with Sales ramping in Q3
The big Cannabis-infused product bull market of 2019 didn’t exactly pan out like so many had believed following the landmark US Farm Bill, momentum from regulatory authorities, and a spate of high-profile Fortune 500 JV moves (ie Molson Coors and HEXO, Altria and CRON, Constellation Brands and Canopy, etc) that seemed to suggest the writing was on the wall for this transformational trend to get in gear.
What happens when everyone gets excited about a big investment theme too early? That’s right! A destructive and painful bear market. This has been story for the whole cannabis space for the past year.
However, given a purging in the pot stock space and new regulatory measures now in place for cannabis-infused beverages in Canada and California, the explosive trend in cannabis beverages can now take flight.
We believe two points are key here for investors: 1. Cannabis-infused beverage leadership investments will be far superior to non-beverage plays in the cannabis sector because of the higher barrier to entry in terms of facilities, expertise, and regulatory hurdles, and 2. BevCanna Enterprises Inc. (OTCMKTS:BVNNF) (CSE:BEV) is likely to emerge as the big speculative winner this year in that niche given a number of inherent advantages and a proactive production ramping process that has already started to take hold.
As the cannabis space heals, BevCanna is supremely positioned to assume a leadership role in a space that is defined more by new adopters than by long-time cannabis consumers. Growth is being driven by new cannabis consumers exploring the marketplace given the expanded legality of cannabis. And new cannabis consumers are, on the margin, more likely to choose new ways of consuming cannabis – ie, many don’t want to smoke it.
According to Brightfield Group researchers, cannabis-infused beverages will represent one of the fastest growing segments of the overall cannabis product complex over the next 10 years. Fior Markets found that the global cannabis beverages market could generate $4.57 billion by 2025. Companies delivering cannabis drinks in Canada in 2020 will be set up for market dominance over the next 5-10 years as the trend takes flight.
BevCanna Enterprises Inc. (OTCMKTS:BVNNF) (CSE:BEV) shares are perfectly positioned to capitalize on this trend, which makes the company a likely candidate for some M&A chatter as cannabis-infused beverages expand to conquer the North American consumer this year.
BevCanna’s Inherent Advantages
BevCanna Enterprises Inc. (CSE:BEV, OTCMKTS:BVNNF) bills itself as an emerging leader in infused beverage manufacturing. The company develops and manufactures cannabinoid-infused beverages and consumer products for in-house brands and white label clients.
BVNNF has been in development-stage operations since IPO-ing last summer. According to recent company communications, the stage is set for a rapid transformation to full commercial-stage operations, with sales likely to hit full volume in Canadian and California markets starting in Q3 of this year.
The company runs a 40k sq ft HACCP certified manufacturing facility, with a current bottling capacity of up to 210M bottles per annum.
The facility is state-of-the-art, with the capability of producing custom bottle form factors and water-soluble cannabinoids. This opens up an immediately obvious leadership potential for white-label product development to complement the company’s in-house brands.
The company also has access to a 100+ acre outdoor cultivation site with an on-site natural spring aquifer.
The team is also a top-draw, with former leaders at Vega, Mike’s Hard Lemonade, and other top disruptive brands and companies in the functional beverage and wellness markets and highly-regulated markets, as well as veterans from Goldman Sachs, Frito Lay, and General Mills. So, they know how to commercialize into big market opportunities.
In other words, this is a company with a world-class facility and a world-class team. And they will be receiving their cannabis-infused beverage production license very soon (They already have the research and cultivation licenses).
There’s a high regulatory barrier to entry for the cannabis-infused beverage space. That will keep competition suppressed, leaving the big profits to be made those specialist players with the resources, equipment, expertise, and regulatory clearance to dominate this high-growth market niche.
BevCanna Enterprises Inc. (OTCMKTS:BVNNF) (CSE:BEV) may be the best of breed the publicly traded markets right now among companies that meet all of these criteria. More to the point, the company is on track to have some of the first cannabis-infused beverages on the market as this phase of the cannabis revolution just gets off the ground.
The Company recently announced that it is significantly expanding its manufacturing premises in anticipation of receiving its standard processing license and initiating full-scale commercialization this year.
In other words, they’re about to gain access to a massive and thriving market looking for cannabis-infused beverages. And the company wants to be ready to soak up every dime of potential sales right out of the gate. So these folks, being experienced business leaders, are getting ready to meet that demand with an increased capacity to produce product supplies when the bell rings and the government says “Go!”.
“This expansion is an exciting step for BevCanna,” said John Campbell, Chief Strategy Officer at BevCanna. “We expect to receive our standard processing license imminently, and we’re preparing to initiate full-scale production in the coming months. We’ve seen a fantastic consumer and industry response to the upcoming Canadian beverage market, and this development ensures that we have capacity and full product offerings to fulfil the anticipated demand.”
Just before that, the company announced that it has entered into a definitive joint venture agreement with Mota Ventures Corp. (CSE:MOTA FSE: 1WZ:GR OTC: PEMTF), to exclusively distribute BevCanna’s hemp-derived products in the European market.
That followed the company’s announcement that it is working with partner Nextleaf Solutions Ltd. (Nextleaf) (CSE:OILS, OTCQB:OILFF, FSE:L0MA), to employ their nano-delivery technology in BevCanna’s upcoming lines of cannabis-infused beverages. BevCanna will have the exclusive rights to commercialize this unique technology, giving the company yet another edge as a market leader in white label services.
According to the release, Nextleaf, BevCanna’s exclusive provider of water-soluble cannabinoids, has completed its acquisition of the intellectual property pertaining to the nano-delivery of cannabinoids. The acquisition includes the foundational processing methodology and two water-soluble formulations. Nextleaf intends to seek patent protection around the acquired IP and to partner with BevCanna to develop a new patent family around infused beverages.
“The IP allows consumers to feel the desired effect from cannabis-infused beverages in under 10 minutes,” said John Campbell, Chief Strategy Officer at BevCanna. “We’re eager to commercialize this innovative technology in Canada; and to act as the exclusive beverage commercialization partner, through BevCanna’s branded and white-label cannabis-infused beverages.”
Looking ahead, the company expects to receive its full license imminently, and then begin full commercial operations. In other words, this is the most exciting time to come across this stock: right in front of its most dramatic and market-moving catalysts, including full-licensing, initial product shipment, expanding sales, expanding markets, topline growth, and everything that analysts and investors typically scan for when hunting new speculative opportunities.
Right now, you have a chance at it ahead of that crowd.
One of the key points to make here is the stock’s relative strength. The cannabis equity sector has been destroyed over the past 6-12 months, and many are still in crash mode. At the same time, BVNNF shares show clear evidence of a major accumulation bid likely by smart money working to expand exposure ahead of the coming parade of high-profile catalysts just ahead for the stock.
Shares are sitting above major moving averages, but well-consolidated and ready for a potential next-leg higher if trendline resistance above the $0.33-0.35 area is cleared. This breakout would be very well supported given the nature of the stock’s basing process, which came on rising volume and bullish divergence on MACD.
About BevCanna Enterprises
BevCanna Enterprises Inc. (OTCMKTS:BVNNF) (CSE:BEV) develops and manufactures cannabinoid-infused beverages and consumer products for in-house brands and white label clients.
With decades of experience creating, branding and distributing iconic brands that have resonated with consumers on a global scale, the team demonstrates an expertise unmatched in the emerging cannabis beverage category.
Based in British Columbia, Canada, BevCanna has a 292-acre outdoor cultivation site in the Okanagan Valley and the exclusive rights to a pristine spring water aquifer, access to a world-class 40,000-square-foot, HACCP certified manufacturing facility, with a current bottling capacity of up to 210M bottles per annum.
BevCanna’s vision is to be a global leader in infused innovations.
- BevCanna Enterprises Inc. (OTCMKTS:BVNNF) (CSE:BEV) is about to receive its full cannabis-infused production license, which will allow the company to start ramping up full commercial operations as a likely leadership name in the Cannabis Bev space
- BevCanna Enterprises Inc. (OTCMKTS:BVNNF) (CSE:BEV) has a small trading float of just 38.3M, which suggests the stock could launch higher on any additional influx of interest.
- BevCanna Enterprises Inc. (OTCMKTS:BVNNF) (CSE:BEV) has a world-class facility and team, positioning the company as a dominant entity in the relatively closed loop of Canadian Cannabis-infused beverage producers
- BevCanna Enterprises Inc. (OTCMKTS:BVNNF) (CSE:BEV) has been demonstrating clear relative strength, outperforming peers in the cannabis space by a wide margin during the recent tailspin in the pot stock sector.
- BevCanna Enterprises Inc. (OTCMKTS:BVNNF) (CSE:BEV) just recorded a MACD Bullish divergence on a rising-volume base, suggesting a technical change in trend with upside breakout potential above.
- BevCanna Enterprises Inc. (OTCMKTS:BVNNF) (CSE:BEV) is set to start clocking big sales growth over coming months with innovative in-house branded products and a thriving white-label business targeting Canada and California
To circle back around, the cannabis bear market has come and possibly gone. And now it’s time to start picking through the rubble because there are probably some life-altering investment opportunities just lying around the floor right now in this space.
Our thesis remains: 1. Cannabis-infused beverages will offer more growth with less competition if you stick to best-of-breed plays, and 2. BevCanna, with its world-class state-of-the-art massive facility and blue-chip team with leadership experience in major markets across similar sectors, is about to gain its fully licensed access to that marketplace. And when that happens, BVNNF will be that best-of-breed name in the cannabis-infused beverage marketplace.
Benefits of CBD You Must Know
CBD has been with us for hundreds of years, used by ancients as a natural remedy for a lot of common ailments. It is only one of more than a hundred chemical compounds found in the hemp or cannabis plant. CBD-infused products like CBD oil, CBD softgel capsules, CBD cream, and others have become appealing alternatives for people seeking relief.
CBD oil gets extracted from the hemp plant, then diluted with a carrier oil such as hemp seed or coconut oil. It’s fast becoming popular in wellness and health circles as an option in the treatment of chronic pain, anxiety, and other symptoms brought about by certain disorders.
The benefits of CBD
Because of CBD’s vast variety and reach, it’s used in various mediums of treatment. Like any other medication introduced to the body, your body needs time for adjustment. CBD can help with symptoms but don’t expect overnight results.
It’s generally recommended to use CBD between 30 to 60 days before witnessing any significant impact. If you decide to try CBD, here are some benefits to look forward to:
• Pain relief
Research has shown that CBD has analgesic properties. This means it’s effective for pain relief. When introduced into the body, CBD can impact the endocannabinoid system’s receptor activity resulting in the reduction of inflammation and the interaction with neurotransmitters.
• Stress relief
In this modern age, many people have experienced feeling overworked or over-booked and this affects their abilities to prioritize through the chaos. In simpler words, they feel stressed.
This is where CBD oil can help as using it can ease the anxieties and worries of everyday life. When used, CBD can calm the nerves which, in turn, allows us to focus more on the tasks at hand.
• Improve sleep
CBD may support our need for a deeper and more restful sleep by reducing chronic anxiety, pain, and the other challenges which prevent us from falling into a deep sleep. Its use can diminish REM sleep disorder too. REM during deep sleep paralyzes the body. This inhibits physical reactions to dreams.
• May help reduce depression and anxiety
Two of the most common mental health problems plaguing the world today are depression and anxiety, both of which can have a devastating impact on one’s health and well-being. Many have attested that the use of CBD oil as effective in the treatment of these disorders. Many are now showing interest in CBD as a natural approach to get back a semblance of normalcy in their lives.
CBD also has anti-depressant properties and these have been linked to its ability to act on the brain’s serotonin receptors, a neurotransmitter compound that regulates social behavior and mood.
• Improve the health of your skin
Today, we find so many lotions, body butter, and hydrating products available in drugstores but are these the right products to reach the moisture levels the body thirsts for? Maybe, but a sure option that can quench such thirst is CBD oil or CBD cream. This is a powerful topical which can help the skin maintain optimal skin moisture.
• It’s non-addictive
Another great quality of CBD is that it’s non-addictive. This means you can keep using the same dose in your treatment without worrying about feeling craving for more. As a matter of fact, the more you use it, the better the results. The body doesn’t build up a tolerance to CBD.
Speak with your doctor about using CBD
There’s continuing research on CBD’s potential role in alleviating pain and other symptoms of common health issues. It might even end up as a natural alternative in the treatment of pain. As research goes on, expect the discovery of new therapeutic and medical uses for this compound.
There’s much more to discover about the safety and efficacy of CBD products. But based on the most recent studies, it’s suggested that CBD may provide a powerful and safe treatment for several prevailing health issues. This is especially true if you purchase your CBD products from high-quality manufacturers like Greenleaf Farms.
What Works Best for Treating Pain with CBD Tincture, Soft gels or Creams? #CBD Tincture #Best All Organic CBD Cream
Cannabidiol (CBD) products such as oils and topicals have become a popular natural remedy for pain. While research is still underway, first-person accounts of the benefits are taking the world by storm.
New products are popping up in every direction you look from CBD oil and CBD tinctures to CBD cream and CBD soft gel capsules. So, no matter your preference, there is a form of CBD to help you treat your pain. Treating pain and inflammation is part of the many benefits that CBD offers the user. Let’s take a deeper look into CBD and pain:
What is CBD and will it make me high?
Many people are skeptical of using CBD as a remedy because of the connotations that come with using a compound that comes from the cannabis or hemp plant. In fact, CBD is the non-intoxicating compound of the cannabis plant and will not make you ‘high’ as if you were smoking marijuana.
The more well-known compound of the plant, THC (tetrahydrocannabinol) is what creates the high. Some CBD oils carry trace amounts (less than 0.3%) of THC. However, oils derived from hemp rather than cannabis do not contain any THC and these are legal in all 50 states across the USA.
How CBD works to reduce pain
When it comes to CBD and pain, this affects the endocannabinoid system in the human body. The endocannabinoid system creates endocannabinoids (its own cannabinoids). The system receives and translates signals from the endocannabinoids and any cannabinoids from CBD products throughout the body.
The endocannabinoid system regulates a variety of functions in the human body. These include immune system responses, sleep and most notably, pain. While CBD does not directly affect the endocannabinoid system according to available research, it does initiate the activation or inhibitions of certain compounds in the body.
CBD in the body can cause a reduction in the absorption of anandamide, a neurotransmitter that helps to regulate pain. Thus, CBD will cause the body to absorb less anandamide, increasing levels in the bloodstream, leading to relief from pain.
The effects of CBD on inflammation to treat pain
Inflammation is the body’s protective response against harmful stimuli. Inflammation is often accompanied by pain, redness and swelling. By treating the cause of the inflammation, you can relieve the pain you might be feeling.
This is one of the most popular ways that CBD is being used as a natural alternative remedy. Since inflammation is one of the body’s immune responses, it is regulated by the endocannabinoid system. So, once again, CBD interacts with neuroreceptors in the body to deliver an anti-inflammatory effect.
By reducing areas of inflammation in the body, CBD can, therefore, help to relieve the pain caused by inflammation. Sometimes the body triggers inflammation when there is no harm done to the body, such as in the case of many autoimmune diseases. CBD oil can greatly help remedy the symptoms of these diseases.
Finding quality CBD products
When using CBD products to relieve pain, you want to find a high-quality CBD product. Be sure to check the details of the oil, tincture or topical that you intend to buy. You want to look for information such as the THC percentage and ensure it is a hemp-derived CBD (especially if you live in a state that has not yet legalized marijuana).
Purchasing your CBD products from a trusted supplier like Greenleaf Farms will ensure that you are receiving a high-quality product. Their hemp is grown under the perfect conditions with no pesticides or herbicides used.
When purchasing from a trusted supplier, it generally comes with the guarantee that you are receiving a pure and authentic CBD to treat and relieve your pain and inflammation. You can also rest easy knowing that your CBD product has been produced with care and your health in mind.